CGN Nuclear Technology Development Co., Ltd. carries a market capitalization of 6.13B, placing it among publicly traded companies globally. Its enterprise value stands at 10.41B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.13B |
| Enterprise Value | 10.41B |
CGN Nuclear Technology Development Co., Ltd. currently has 945.43M shares outstanding.
| Shares Outstanding | 945.43M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 1.37, and the price-to-book ratio stands at 4.78.
| PE Ratio | N/A |
| PS Ratio | 1.37 |
| PB Ratio | 4.78 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | 17.58 |
| P/OCF Ratio | N/A |
| EV / Sales | 1.75 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 18.81 |
CGN Nuclear Technology Development Co., Ltd. maintains a current ratio of 1.79, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 63.40, indicating elevated leverage, while an interest coverage ratio of -1.87 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.79 |
| Quick Ratio | 0.42 |
| Debt / Equity | 63.40 |
| Debt / EBITDA | -21.82 |
| Interest Coverage | -1.87 |
| Return on Equity (ROE) | -19.92 |
| Return on Assets (ROA) | -3.43 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.59 |
| Income Tax | 29.92M |
| Effective Tax Rate | N/A |
CGN Nuclear Technology Development Co., Ltd.'s stock has declined approximately -27.91991% over the past 52 weeks. The 50-day moving average sits at 7.39, while the 200-day moving average is 8.09.
| Beta (5Y) | N/A |
| 52-Week Price Change | -27.91991% |
| 50-Day Moving Average | 7.39 |
| 200-Day Moving Average | 8.09 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, CGN Nuclear Technology Development Co., Ltd. generated 5.93B in revenue and converted that into -375.41M in net income, yielding earnings per share of -0.41. EBITDA reached -158.43M, while operating income came in at -158.43M.
| Revenue | 5.93B |
| Gross Profit | 779.09M |
| Operating Income | -158.43M |
| Pretax Income | -354.82M |
| Net Income | -375.41M |
| EBITDA | -158.43M |
| EBIT | -158.43M |
| Earnings Per Share (EPS) | -0.41 |
CGN Nuclear Technology Development Co., Ltd. holds 1.48B in cash and equivalents against 3.46B in total debt, resulting in a net debt position of 1.58B. Total book value stands at 1.70B, with working capital of 2.76B providing operational flexibility.
| Cash & Cash Equivalents | 1.48B |
| Total Debt | 3.46B |
| Net Debt | 1.58B |
| Equity (Book Value) | 1.70B |
| Book Value Per Share | 1.79 |
| Working Capital | 2.76B |
After subtracting -461.44M in capital expenditures, free cash flow totaled -461.44M - equivalent to -0.49 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -461.44M |
| Free Cash Flow | -461.44M |
| FCF Per Share | -0.49 |
CGN Nuclear Technology Development Co., Ltd. operates with a gross margin of 13.13, reflecting its pricing power and cost economics. The operating margin of -2.67 and net profit margin of -6.33 provide insight into operational efficiency.
| Gross Margin | 13.13 |
| Operating Margin | -2.67 |
| Pretax Margin | -5.98 |
| Profit Margin | -6.33 |
| EBITDA Margin | -2.67 |
The company's payout ratio of -18.54 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.08 |
| Dividend Yield | N/A |
| Payout Ratio | -18.54 |
| Shareholder Yield | 0.87 |
| FCF Yield | 5.69 |
CGN Nuclear Technology Development Co., Ltd.'s most recent stock split took place on May 15, 2001 with a 5:8 split ratio.
| Last Split Date | 5/15/2001 |
| Split Ratio | 5:8 |
CGN Nuclear Technology Development Co., Ltd. posts an Altman Z-Score of 2.00, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.00 |